Literature DB >> 17405690

The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction.

Mark C Houston1.   

Abstract

Mercury, cadmium, and other heavy metals have a high affinity for sulfhydryl (-SH) groups, inactivating numerous enzymatic reactions, amino acids, and sulfur-containing antioxidants (NAC, ALA, GSH), with subsequent decreased oxidant defense and increased oxidative stress. Both bind to metallothionein and substitute for zinc, copper, and other trace metals reducing the effectiveness of metalloenzymes. Mercury induces mitochondrial dysfunction with reduction in ATP, depletion of glutathione, and increased lipid peroxidation; increased oxidative stress is common. Selenium antagonizes mercury toxicity. The overall vascular effects of mercury include oxidative stress, inflammation, thrombosis, vascular smooth muscle dysfunction, endothelial dysfunction, dyslipidemia, immune dysfunction, and mitochondrial dysfunction. The clinical consequences of mercury toxicity include hypertension, CHD, MI, increased carotid IMT and obstruction, CVA, generalized atherosclerosis, and renal dysfunction with proteinuria. Pathological, biochemical, and functional medicine correlations are significant and logical. Mercury diminishes the protective effect of fish and omega-3 fatty acids. Mercury, cadmium, and other heavy metals inactivate COMT, which increases serum and urinary epinephrine, norepinephrine, and dopamine. This effect will increase blood pressure and may be a clinical clue to heavy metal toxicity. Cadmium concentrates in the kidney, particularly inducing proteinuria and renal dysfunction; it is associated with hypertension, but less so with CHD. Renal cadmium reduces CYP4A11 and PPARs, which may be related to hypertension, sodium retention, glucose intolerance, dyslipidemia, and zinc deficiency. Dietary calcium may mitigate some of the toxicity of cadmium. Heavy metal toxicity, especially mercury and cadmium, should be evaluated in any patient with hypertension, CHD, or other vascular disease. Specific testing for acute and chronic toxicity and total body burden using hair, toenail, urine, serum, etc. with baseline and provoked evaluation should be done.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405690

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  56 in total

Review 1.  Fluoride Exposure and Blood Pressure: a Systematic Review and Meta-Analysis.

Authors:  Meng Li; Yannan Zhao; Xiaolin Tian; Penghui Liu; Jiaxin Xie; Nisha Dong; Jing Feng; Yi Gao; Ye Fan; Yulan Qiu; Fengjie Tian; Xiaoyan Yan
Journal:  Biol Trace Elem Res       Date:  2020-06-30       Impact factor: 3.738

2.  Selenium protects against cadmium-induced kidney apoptosis in chickens by activating the PI3K/AKT/Bcl-2 signaling pathway.

Authors:  Rong-Kun Bao; Shu-Fang Zheng; Xin-Yue Wang
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-13       Impact factor: 4.223

3.  Human health impacts of exposure to metals through extreme consumption of fish from the Colombian Caribbean Sea.

Authors:  Fabio Fuentes-Gandara; José Pinedo-Hernández; José Marrugo-Negrete; Sergi Díez
Journal:  Environ Geochem Health       Date:  2016-11-22       Impact factor: 4.609

4.  Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species.

Authors:  Lorena B Furieri; María Galán; María S Avendaño; Ana B García-Redondo; Andrea Aguado; Sonia Martínez; Victoria Cachofeiro; M Visitación Bartolomé; María J Alonso; Dalton V Vassallo; Mercedes Salaices
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies.

Authors:  Subat Turdi; Weixia Sun; Yi Tan; Xiaohui Yang; Lu Cai; Jun Ren
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-10       Impact factor: 2.557

6.  Low-level mercury can enhance procoagulant activity of erythrocytes: a new contributing factor for mercury-related thrombotic disease.

Authors:  Kyung-Min Lim; Sujin Kim; Ji-Yoon Noh; Keunyoung Kim; Won-Hee Jang; Ok-Nam Bae; Seung-Min Chung; Jin-Ho Chung
Journal:  Environ Health Perspect       Date:  2010-03-12       Impact factor: 9.031

7.  Sex differences in the relationship between blood mercury concentration and metabolic syndrome risk.

Authors:  Ji-Youn Chung; Min-Seok Seo; Jae-Yong Shim; Yong-Jae Lee
Journal:  J Endocrinol Invest       Date:  2014-07-23       Impact factor: 4.256

8.  Association of serum lead and mercury level with cardiometabolic risk factors and liver enzymes in a nationally representative sample of adolescents: the CASPIAN-III study.

Authors:  Parinaz Poursafa; Ehsan Ataee; Mohammad Esmaeel Motlagh; Gelayol Ardalan; Mohammad Hassan Tajadini; Maryam Yazdi; Roya Kelishadi
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-15       Impact factor: 4.223

9.  Cadmium exposure in association with history of stroke and heart failure.

Authors:  Junenette L Peters; Todd S Perlstein; Melissa J Perry; Eileen McNeely; Jennifer Weuve
Journal:  Environ Res       Date:  2010-01-08       Impact factor: 6.498

10.  Additive effect of heavy metals on metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010.

Authors:  Seong-Su Moon
Journal:  Endocrine       Date:  2013-09-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.